Cover Image
市場調查報告書

胰島素輸送設備市場分析:各產品 (胰島素注射筒、胰島素筆針、胰島素幫浦、胰島素注射器)、各最終用途 (醫院、居家醫療、看護設施、養老院)的市場區隔預測

Insulin Delivery Devices Market Analysis By Product (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Injectors), By End Use (Hospitals, Homecare, Assisted Living Centers, & Nursing Homes), And Segment Forecasts, 2014 - 2025

出版商 Grand View Research, Inc. 商品編碼 408937
出版日期 內容資訊 英文 80 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
胰島素輸送設備市場分析:各產品 (胰島素注射筒、胰島素筆針、胰島素幫浦、胰島素注射器)、各最終用途 (醫院、居家醫療、看護設施、養老院)的市場區隔預測 Insulin Delivery Devices Market Analysis By Product (Insulin Syringes, Insulin Pens, Insulin Pumps, Insulin Injectors), By End Use (Hospitals, Homecare, Assisted Living Centers, & Nursing Homes), And Segment Forecasts, 2014 - 2025
出版日期: 2016年11月07日 內容資訊: 英文 80 Pages
簡介

本報告提供全球胰島素輸送設備市場相關調查,市場趨勢,各產品,各最終用途,各地區趨勢,及打入市場的主要企業簡介等彙整資料。

第1章 調查方法

第2章 摘要整理

第3章 市場變動,趨勢,範圍

  • 市場區隔和範圍
  • 市場趨勢
    • 促進要素分析
    • 阻礙要素分析
  • 被優先的主要的機會
  • SWOT分析:要因別
  • 產業分析:波特
  • 競爭環境

第4章 市場類別1:各產品預測、趨勢分析

  • 各產品趨勢分析
  • 胰島素注射筒
  • 胰島素筆針
  • 胰島素幫浦
  • 胰島素注射器

第5章 市場類別2:各最終用途預測、趨勢分析

  • 各最終用途趨勢分析
  • 醫院
  • 居家醫療
  • 其他

第6章 市場類別3:各地區預測、趨勢分析

  • 各地區趨勢分析與市場佔有率:2016年,2025年
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東、非洲

第7章 競爭環境

目錄
Product Code: GVR-1-68038-991-3

The insulin delivery devices market is expected to reach USD 19.8 billion by 2025, according to a new report by Grand View Research, Inc. The global industry is estimated to witness a high growth during the forecast period from 2016 to 2025. Rapidly increasing number of diabetics coupled with the escalating attention around diabetes care is a major factor propelling the market.

Obesity, sedentary lifestyles, and unhealthy food habits, primarily in the young population, lead to the occurrence of diabetes. In addition, growing diabetic geriatric population is another factor supporting the growth of this vertical. According to the United Nations, Department of Economic and Social Affairs, around 901 million individuals were aged 60 or over in 2015 and this number is projected to increase to 1.4 billion by 2030. Thus, the enlarging elderly population is expected to boost the demand for insulin delivery devices.

Technological innovations and advancements are an ongoing trend in this vertical. Also, favorable reimbursement policies for these devices, mainly in developed countries like the U.S. and Germany, are anticipated to fuel the market growth during the study period. However, stringent regulatory requirements regulating the approval of insulin delivery devices is a major factor restraining the growth of this industry.

Further Key Findings from the Study Suggest:

  • The insulin pens segment was the largest revenue-generating category of this market in 2015. The pen is equipped with self-contained cartridges and offers ease in handling & less pain while injecting insulin. Advantages of these pen devices over other products are resulting in its growing popularity, thus serving as a vital factor in contributing to the sector's highest share in this market.
  • Homecare is estimated to be the largest shareholder and the fastest growing segment due to increased adoption of self-care diabetes management devices and the availability of simplified and user-friendly product designs for patients.
  • North America is the leading regional sector and accounted for the largest revenue share in 2015 primarily due to the favorable reimbursement scenario in this space. Also, the presence of major manufacturers in this region is supporting the market growth.
  • The Asia Pacific region is anticipated to be the fastest growing market during the forecast period. The high prevalence rate of diabetes in the Asian countries, such as China and India, is a major factor contributing to market expansion in this region.
  • Some key players serving this vertical include Novo Nordisk A/S; Sanofi; Eli Lilly and Company; Medtronic; Becton, Dickinson and Company; Abbott; and F. Hoffmann-La Roche Ltd.

Table of Content

Chapter 1. Research Methodology

  • 1.1. Information Procurement
  • 1.2. Data Analysis

Chapter 2. Executive Summary

  • 2.1. Market Snapshot

Chapter 3. Market Variables, Trends & Scope

  • 3.1. Market Segmentation & Scope
  • 3.2. Insulin delivery devices: Market dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraints analysis
  • 3.3. Key Opportunities Prioritized
  • 3.4. Insulin delivery devices - SWOT Analysis, by Factor (Political & Legal, Economic, and Technological)
  • 3.5. Industry Analysis - Porter's
  • 3.6. Competitive Landscape: Market Position Analysis

Chapter 4. Market Categorization 1: Product Estimates & Trend Analysis

  • 4.1. Insulin delivery devices: Product Movement Analysis
  • 4.2. Insulin syringes
    • 4.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.3. Insulin pens
    • 4.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.4. Insulin pumps
    • 4.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 4.5. Insulin injectors
    • 4.5.1. Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 5. Market Categorization 2: By End-Use, Estimates & Trend Analysis

  • 5.1. Insulin delivery devices: Technology Movement Analysis
  • 5.2. Hospital
    • 5.2.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.3. Homecare
    • 5.3.1. Market estimates and forecasts, 2014 - 2025 (USD Million)
  • 5.4. Others
    • 5.4.1. Market estimates and forecasts, 2014 - 2025 (USD Million)

Chapter 6. Market Categorization 5: Regional Estimates & Trend Analysis

  • 6.1. Insulin Delivery Devices Market Share (%) Analysis, by Region 2016 & 2025
  • 6.2. North America
    • 6.2.1. U.S.
      • 6.2.1.1. U.S. insulin delivery devices market, by product, 2014 - 2025 (USD Million)
      • 6.2.1.2. U.S. insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
    • 6.2.2. Canada
      • 6.2.2.1. Canada insulin delivery devices market, by product, 2014 - 2025 (USD Million)
      • 6.2.2.2. Canada insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 6.3. Europe
    • 6.3.1. Germany
      • 6.3.1.1. Germany insulin delivery devices market, by product, 2014 - 2025 (USD Million)
      • 6.3.1.2. Germany insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK insulin delivery devices market, by product, 2014 - 2025 (USD Million)
      • 6.3.2.2. UK insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. China
      • 6.4.1.1. China insulin delivery devices market, by product, 2014 - 2025 (USD Million)
      • 6.4.1.2. China insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
    • 6.4.2. India
      • 6.4.2.1. India insulin delivery devices market, by product, 2014 - 2025 (USD Million)
      • 6.4.2.2. India insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Brazil
      • 6.5.1.1. Brazil insulin delivery devices market, by product, 2014 - 2025 (USD Million)
      • 6.5.1.2. Brazil insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
    • 6.5.2. Mexico
      • 6.5.2.1. Mexico insulin delivery devices market, by product, 2014 - 2025 (USD Million)
      • 6.5.2.2. Mexico insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 6.6. MEA
    • 6.6.1. South Africa
      • 6.6.1.1. South Africa insulin delivery devices market, by product, 2014 - 2025 (USD Million)
      • 6.6.1.2. South Africa insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia insulin delivery devices market, by product, 2014 - 2025 (USD Million)
      • 6.6.2.2. Saudi Arabia insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Profiles
  • 7.2. Novo Nordisk A/S
    • 7.2.1. Company overview
    • 7.2.2. Financial performance
    • 7.2.3. Product benchmarking
    • 7.2.4. Strategic initiatives
  • 7.3. Sanofi
    • 7.3.1. Company overview
    • 7.3.2. Financial performance
    • 7.3.3. Product benchmarking
    • 7.3.4. Strategic initiatives
  • 7.4. Eli Lilly and Company
    • 7.4.1. Company overview
    • 7.4.2. Financial performance
    • 7.4.3. Product benchmarking
    • 7.4.4. Strategic initiatives
  • 7.5. Biocon Ltd.
    • 7.5.1. Company overview
    • 7.5.2. Financial performance
    • 7.5.3. Product benchmarking
    • 7.5.4. Strategic initiatives
  • 7.6. Ypsomed AG
    • 7.6.1. Company overview
    • 7.6.2. Financial performance
    • 7.6.3. Product benchmarking
    • 7.6.4. Strategic initiatives
  • 7.7. Wockhardt Ltd.
    • 7.7.1. Company overview
    • 7.7.2. Financial performance
    • 7.7.3. Product benchmarking
    • 7.7.4. Strategic initiatives
  • 7.8. Medtronic
    • 7.8.1. Company overview
    • 7.8.2. Financial performance
    • 7.8.3. Product benchmarking
    • 7.8.4. Strategic initiatives
  • 7.9. Abbott Laboratories
    • 7.9.1. Company overview
    • 7.9.2. Financial performance
    • 7.9.3. Product benchmarking
    • 7.9.4. Strategic initiatives
  • 7.10. F. Hoffmann-La Roche, Ltd.
    • 7.10.1. Company overview
    • 7.10.2. Financial performance
    • 7.10.3. Product benchmarking
    • 7.10.4. Strategic initiatives

List of Tables

  • 1. North America insulin delivery devices market, by country, 2014 - 2025 (USD Million)
  • 2. North America insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 3. North America insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 4. U.S. insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 5. U.S. insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 6. Canada insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 7. Canada insulin delivery devices market, by end user, 2014 - 2025 (USD Million)
  • 8. Europe insulin delivery devices market, by country, 2014 - 2025 (USD Million)
  • 9. Europe insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 10. Europe insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 11. Germany insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 12. Germany insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 13. UK insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 14. UK insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 15. Asia Pacific insulin delivery devices market, by country, 2014 - 2025 (USD Million)
  • 16. Asia Pacific insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 17. Asia Pacific insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 18. China insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 19. China insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 20. India insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 21. India insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 22. Latin America insulin delivery devices market, by country, 2014 - 2025 (USD Million)
  • 23. Latin America insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 24. Latin America insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 25. Brazil insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 26. Brazil insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 27. Mexico insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 28. Mexico insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 29. MEA insulin delivery devices market, by country, 2014 - 2025 (USD Million)
  • 30. MEA insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 31. MEA insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 32. South Africa insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 33. South Africa insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)
  • 34. Saudi Arabia insulin delivery devices market, by product, 2014 - 2025 (USD Million)
  • 35. Saudi Arabia insulin delivery devices market, by end-use, 2014 - 2025 (USD Million)

List of Figures

  • 1. Market summary
  • 2. Market trends & outlook
  • 3. Insulin delivery devices: Market segmentation
  • 4. Market driver relevance analysis (Current & future impact)
  • 5. Penetration & growth prospect mapping
  • 6. SWOT analysis, by factor (Political & legal, economic and technological)
  • 7. Insulin delivery devices Porter's analysis
  • 8. Insulin delivery devices market: Product outlook key takeaways
  • 9. Insulin delivery devices market: Product movement analysis
  • 10. Global insulin syringes market, 2014 - 2025 (USD Million)
  • 11. Global insulin pumps market, 2014 - 2025 (USD Million)
  • 12. Global insulin pens market, 2014 - 2025 (USD Million)
  • 13. Global insulin injectors market, 2014 - 2025 (USD Million)
  • 14. Insulin delivery devices market: End-use outlook key takeaways
  • 15. Insulin delivery devices market: End-use movement analysis
  • 16. Global hospitals market, 2014 - 2025 (USD Million)
  • 17. Global homecare market, 2014 - 2025 (USD Million)
  • 18. Global other market, 2014 - 2025 (USD Million)
  • 19. Regional market place: Key takeaways
  • 20. Regional outlook, 2016 & 2025
Back to Top